The latest results from the European STAR-II trial of MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery device (MIGS), will be presented at the 39th edition of the European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting. ESCRS is taking place between October 8 and 11 in Amsterdam, the Netherlands.
Professor Julián García Feijoó, Universidad Complutense, Madrid Spain, and one of the STAR-II trial investigators, will present the positive 18-month efficacy and safety data from STAR-II and discuss them live on Monday 11 October at 12:30 CET in Hall 9.
In addition, promising preliminary, interim three-year data on MINIjectTM from the STAR-I trial will be presented ‘on-demand’ by Professor Philippe Denis, Hôpital de la Croix-Rousse, Lyon, France (Poster ID: PP002).
ESCRS is amongst the first international congresses to go back to face-to-face interactions and will take place in a hybrid format this year, including in person and online attendance.
